2020
Ophthalmic Medication Expenditures and Out-of-Pocket Spending An Analysis of United States Prescriptions from 2007 through 2016
Chen EM, Kombo N, Teng CC, Mruthyunjaya P, Nwanyanwu K, Parikh R. Ophthalmic Medication Expenditures and Out-of-Pocket Spending An Analysis of United States Prescriptions from 2007 through 2016. Ophthalmology 2020, 127: 1292-1302. PMID: 32359935, PMCID: PMC7508869, DOI: 10.1016/j.ophtha.2020.04.037.Peer-Reviewed Original ResearchConceptsOphthalmic medicationsMedication expendituresOOP expenditureLongitudinal cohort studyOverall drug expendituresUnited States populationPrescription drug spendingGlaucoma medicationsCohort studyMedication useDry eyePrescription usePrescription expendituresPrescription medicationsOOP expensesMedicationsCopayment assistancePocket expenditureOOP spendingDrug expendituresPocket spendingDrug spendingIndirect costsMEPS participantsLinear regression
2019
Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series
Kim J, Materin MA, Sznol M, Kluger H, Weiss S, Chow J, Stoessel K, Kombo N, Del Priore L, Pointdujour-Lim R. Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series. Ophthalmology 2019, 126: 1058-1062. PMID: 30735682, PMCID: PMC6933747, DOI: 10.1016/j.ophtha.2019.01.031.Peer-Reviewed Original Research